170(top 100%)
PR articles
66.1K(top 0.1%)
PR citations
58(top 100%)
PR h-index
67(top 100%)
h-index
238
documents
81.2K
doc citations
7.3K
citing journals
100
times ranked

Publications

173 PR articles • 74,796 PR citations • Sorted by year • Download PDF (PDF by citations)
#ArticleIFPR CitationsLinks
1Combined Impact of Migraine and Pregnancy-Induced Hypertension on Long-term Risk of Premature Myocardial Infarction and Stroke
Neurology, 2024, 102,
1.010Citations (PDF)
2The combined impact of migraine and gestational diabetes on long‐term risk of premature myocardial infarction and stroke: A population‐based cohort study
Headache, 2024, 64, 1124-1134
3.12Citations (PDF)
3Migraine and risk of premature myocardial infarction and stroke among men and women: A Danish population-based cohort study
PLoS Medicine, 2023, 20, e1004238
8.513Citations (PDF)
4The Evolving Usefulness of the Test-negative Design in Studying Risk Factors for COVID-19
Epidemiology, 2022, 33, e7-e8
2.919Citations (PDF)
5Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration0.67Citations (PDF)
6Educational note: types of causes5.16Citations (PDF)
7A Test-Negative Design with Additional Population Controls Can Be Used to Rapidly Study Causes of the SARS-CoV-2 Epidemic
Epidemiology, 2020, 31, 836-843
2.965Citations (PDF)
8Community-Acquired <i>Escherichia coli</i> Bacteremia after Age 50 and Subsequent Incidence of a Cancer Diagnosis: A Danish Population–Based Cohort Study1.23Citations (PDF)
9COSMOS-E: Guidance on conducting systematic reviews and meta-analyses of observational studies of etiology
PLoS Medicine, 2019, 16, e1002742
8.5430Citations (PDF)
10Test-Negative Designs
Epidemiology, 2019, 30, 838-844
2.983Citations (PDF)
11Re: Is the Smog Lifting?
Epidemiology, 2019, 30, e37-e37
2.93Citations (PDF)
12Exposure Opportunity: The Advantages of Including Men in Analyses of Female-Related Risk Factors3.44Citations (PDF)
13Confounding in observational studies based on large health care databases: problems and potential solutions &amp;ndash; a primer for the clinician
Clinical Epidemiology, 2017, Volume 9, 185-193
2.9160Citations (PDF)
14Effect modification, interaction and mediation: an overview of theoretical insights for clinical investigators
Clinical Epidemiology, 2017, Volume 9, 331-338
2.9210Citations (PDF)
15Causality and causal inference in epidemiology: the need for a pluralistic approach5.1275Citations (PDF)
16Noninferiority is (too) common in noninferiority trials3.79Citations (PDF)
17Performing Survival Analyses in the Presence of Competing Risks: A Clinical Example in Older Breast Cancer Patients4.795Citations (PDF)
18Vandenbroucke and Pearce Respond to “Incident and Prevalent Exposures and Causal Inference”3.46Citations (PDF)
19Risk of venous and arterial thrombotic events in patients diagnosed with superficial vein thrombosis: a nationwide cohort study
Blood, 2015, 125, 229-235
4.275Citations (PDF)
20Preregistration: when shall we start the real discussion?0.36Citations (PDF)
21Point: Incident Exposures, Prevalent Exposures, and Causal Inference: Does Limiting Studies to Persons Who Are Followed From First Exposure Onward Damage Epidemiology?3.462Citations (PDF)
22The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies5.68,553Citations (PDF)
23Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and elaboration5.62,424Citations (PDF)
24Randomized trials with missing outcome data: how to analyze and what to report
Cmaj, 2014, 186, 1153-1157
1.399Citations (PDF)
25RE: Drug risk assessment and data reuse2.00Citations (PDF)
26Commentary
Epidemiology, 2014, 25, 738-741
2.921Citations (PDF)
27Sample size importantly limits the usefulness of instrumental variable methods, depending on instrument strength and level of confounding3.757Citations (PDF)
28Physician’s Preference-based Instrumental Variable Analysis
Epidemiology, 2014, 25, 923-927
2.99Citations (PDF)
29Multisystem Morbidity and Mortality in Cushing's Syndrome: A Cohort Study4.2386Citations (PDF)
30Use of Glucocorticoids and Risk of Venous Thromboembolism
JAMA Internal Medicine, 2013, 173, 743
10.8421Citations (PDF)
31Informed consent and the new EU regulation on data protection5.12Citations (PDF)
32Reporting Instrumental Variable Analyses
Epidemiology, 2013, 24, 937-938
2.97Citations (PDF)
33Trends in Citations to Books on Epidemiological and Statistical Methods in the Biomedical Literature
PLoS ONE, 2013, 8, e61837
2.49Citations (PDF)
34A Mapping Between Interactions and Interference
Epidemiology, 2012, 23, 285-292
2.915Citations (PDF)
35Quantification of Bias in Direct Effects Estimates Due to Different Types of Measurement Error in the Mediator
Epidemiology, 2012, 23, 551-560
2.982Citations (PDF)
36Case-control studies: basic concepts5.1221Citations (PDF)
37Overestimation of risk ratios by odds ratios in trials and cohort studies: alternatives to logistic regression
Cmaj, 2012, 184, 895-899
1.3438Citations (PDF)
38Incidence rates in dynamic populations5.192Citations (PDF)
39On Compulsory Preregistration of Protocols
Epidemiology, 2012, 23, 652
2.90Citations (PDF)
40Reporting of noninferiority trials was incomplete in trial registries3.715Citations (PDF)
41Relationship between Venous and Arterial Thrombosis: A Review of the Literature from a Causal Perspective2.696Citations (PDF)
42Comprehensive evaluations of the adverse effects of drugs: importance of appropriate study selection and data sources2.949Citations (PDF)
43Preregistration of Epidemiologic Studies
Epidemiology, 2010, 21, 619-620
2.930Citations (PDF)
44Health risks encountered by Dutch medical students during an elective in the tropics and the quality and comprehensiveness of pre-and post-travel care2.929Citations (PDF)
45A solution to the problem of studying blood donor–related risk factors when patients have received multiple transfusions
Transfusion, 2010, 50, 1959-1966
0.812Citations (PDF)
46Female donors and transfusion‐related acute lung injury
Transfusion, 2010, 50, 2447-2454
0.850Citations (PDF)
47Efficacy of experimental treatments compared with standard treatments in non-inferiority trials: a meta-analysis of randomized controlled trials5.125Citations (PDF)
48Study did a good job
BMJ: British Medical Journal, 2010, 341, c7042-c7042
0.13Citations (PDF)
49Mejorar la comunicación de estudios observacionales en epidemiología (STROBE): explicación y elaboración
Gaceta Sanitaria, 2009, 23, 158.e1-158.e28
1.1160Citations (PDF)
50STREGA, STROBE, STARD, SQUIRE, MOOSE, PRISMA, GNOSIS, TREND, ORION, COREQ, QUOROM, REMARK… and CONSORT: for whom does the guideline toll?3.7111Citations (PDF)
51Myocardial Infarction Occurs with a Similar 24 h Pattern in the 4G/5G Versions of Plasminogen Activator Inhibitor-1
Chronobiology International, 2009, 26, 637-652
2.04Citations (PDF)
52When One Depends on the Other
Epidemiology, 2009, 20, 161-166
2.9115Citations (PDF)
53A Meta-Analysis of Surgical Treatment for Vestibular Schwannoma
Otology and Neurotology, 2009, 30, 975-980
1.616Citations (PDF)
54Trends in total cholesterol screening and in prescribing lipid-lowering drugs in general practice in the period 1994–20033.17Citations (PDF)
55Declaración de la Iniciativa STROBE (Strengthening the Reporting of Observational studies in Epidemiology): directrices para la comunicación de estudios observacionales
Gaceta Sanitaria, 2008, 22, 144-150
1.1379Citations (PDF)
56The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies3.713,516Citations (PDF)
57Perinatal outcome, health, growth, and medical care utilization of 5- to 8-year-old intracytoplasmic sperm injection singletons
Fertility and Sterility, 2008, 89, 1133-1146
3.082Citations (PDF)
58Cognitive development of singletons born after intracytoplasmic sperm injection compared with in vitro fertilization and natural conception
Fertility and Sterility, 2008, 90, 289-296
3.086Citations (PDF)
59What Do Case-Control Studies Estimate? Survey of Methods and Assumptions in Published Case-Control Research
American Journal of Epidemiology, 2008, 168, 1073-1081
3.4166Citations (PDF)
60Measures of Biological Interaction and the STROBE Statement
Epidemiology, 2008, 19, 519
2.91Citations (PDF)
61Declaración de la iniciativa STROBE (Strengthening the Reporting of Observational Studies in Epidemiology): directrices para la comunicación de estudios observacionales0.5159Citations (PDF)
62The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies*2.21,461Citations (PDF)
63Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
PLoS Medicine, 2007, 4, e297
8.54,967Citations (PDF)
64Matched follow-up study of 5–8 year old ICSI-singletons: comparison of their neuromotor development to IVF and naturally conceived singletons
Human Reproduction, 2007, 22, 1638-1646
1.045Citations (PDF)
65Heredity versus Environment in Tuberculosis in Twins12.268Citations (PDF)
66Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies
BMJ: British Medical Journal, 2007, 335, 806-808
0.18,205Citations (PDF)
67Determinants of methicillin-resistant Staphylococcus aureus carriage in nursing homes
Age and Ageing, 2007, 36, 327-330
1.822Citations (PDF)
68The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement
Epidemiology, 2007, 18, 800-804
2.91,752Citations (PDF)
69Strengthening the Reporting of Observational Studies in Epidemiology (STROBE)
Epidemiology, 2007, 18, 805-835
2.92,359Citations (PDF)
70The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies
Preventive Medicine, 2007, 45, 247-251
2.9996Citations (PDF)
71The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
Lancet, The, 2007, 370, 1453-1457
52.815,585Citations (PDF)
72An Outbreak of Pneumocystis jiroveci Pneumonia with 1 Predominant Genotype among Renal Transplant Recipients: Interhuman Transmission or a Common Environmental Source?
Clinical Infectious Diseases, 2007, 44, 1143-1149
5.4147Citations (PDF)
73The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies
PLoS Medicine, 2007, 4, e296
8.59,468Citations (PDF)
74Clinical predictors of alloimmunization after red blood cell transfusion
Transfusion, 2007, 47, 2066-2071
0.8102Citations (PDF)
75Population screening for single genes that codetermine common diseases in adulthood had limited effects3.72Citations (PDF)
76Preemptive versus Nonpreemptive Simultaneous Pancreas-Kidney Transplantation: A Single-Center, Long-Term, Follow-up Study
Transplantation, 2006, 81, 1119-1124
1.231Citations (PDF)
77Sick leave as a predictor of job loss in patients with chronic arthritis2.133Citations (PDF)
78Serum Troponin T Concentration as a Predictor of Mortality in Hemodialysis and Peritoneal Dialysis Patients1.437Citations (PDF)
79Case reports of suspected adverse drug reactions: Case reports were dismissed too quickly0.113Citations (PDF)
80One-time general consent for research on biological samples: Opt out system for patients is optimal and endorsed in many countries0.119Citations (PDF)
81What is the best evidence for determining harms of medical treatment?
Cmaj, 2006, 174, 645-646
1.374Citations (PDF)
82Incidence of recombinant erythropoietin (EPO) hyporesponse, EPO-associated antibodies, and pure red cell aplasia in dialysis patients
Kidney International, 2005, 68, 1215-1222
5.033Citations (PDF)
83ACE I/D polymorphism is associated with mortality in a cohort study of patients starting with dialysis
Kidney International, 2005, 68, 2237-2243
5.019Citations (PDF)
84RE: “QUALITY OF REPORTING OF OBSERVATIONAL LONGITUDINAL RESEARCH”
American Journal of Epidemiology, 2005, 162, 1032-1033
3.41Citations (PDF)
85Thrombophilia, Clinical Factors, and Recurrent Venous Thrombotic Events17.1504Citations (PDF)
86Case–Control and Two-Gate Designs in Diagnostic Accuracy Studies
Clinical Chemistry, 2005, 51, 1335-1341
1.1453Citations (PDF)
87In an observational study elderly patients had an increased risk of falling due to home hazards3.752Citations (PDF)
88A regression model with unexplained residuals was preferred in the analysis of the fetal origins of adult diseases hypothesis3.7127Citations (PDF)
89Assessing the quality of research0.1325Citations (PDF)
90Specific autoantibodies precede the symptoms of rheumatoid arthritis: A study of serial measurements in blood donors
Arthritis and Rheumatism, 2004, 50, 380-386
6.01,678Citations (PDF)
91Increased levels of C‐reactive protein in serum from blood donors before the onset of rheumatoid arthritis
Arthritis and Rheumatism, 2004, 50, 2423-2427
6.0160Citations (PDF)
92Thrombophilias and gynaecology4.122Citations (PDF)
93Causes of hyponatremia in the Departments of Internal Medicine and Neurosurgery2.918Citations (PDF)
94Re: Oral Contraceptives and the Risk of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers4.75Citations (PDF)
95Balancing benefits and harms in health care: Observational data on harm should complement systematic reviews of benefit
BMJ: British Medical Journal, 2003, 327, 750-a-750
0.14Citations (PDF)
96Alternative treatments in reproductive medicine: The vexing problem of `seemingly impeccable trials....'
Human Reproduction, 2002, 17, 2228-2229
1.02Citations (PDF)
97Alvan Feinstein and the art of consulting3.77Citations (PDF)
98The history of confounding0.020Citations (PDF)
99Survival of Patients with Epilepsy: An Estimate of the Mortality Risk
Epilepsia, 2002, 43, 445-450
4.659Citations (PDF)
100Oral Contraceptives and the Risk of Venous Thrombosis
New England Journal of Medicine, 2001, 344, 1527-1535
43.7532Citations (PDF)
101Antipsychotic medication and venous thrombosis1.993Citations (PDF)
102Changing images of John Snow in the history of epidemiology0.011Citations (PDF)
103High factor VIII levels contribute to the thrombotic risk in families with factor V Leiden
British Journal of Haematology, 2001, 114, 380-386
2.441Citations (PDF)
104Family history and risk of venous thromboembolism with oral contraception
BMJ: British Medical Journal, 2001, 323, 752-752
0.19Citations (PDF)
105Higher Risk of Venous Thrombosis During Early Use of Oral Contraceptives in Women With Inherited Clotting Defects8.6202Citations (PDF)
106Invited Commentary: The Testimony of Dr. Snow3.411Citations (PDF)
107Accuracy and cost-effectiveness of a new strategy to screen for celiac disease in children with Down syndrome
Journal of Pediatrics, 2000, 137, 756-761
2.088Citations (PDF)
108Two Centuries of Mortality in Ten Large Families with Huntington Disease
Epidemiology, 1999, 10, 706-710
2.953Citations (PDF)
109Risk of Venous Thrombosis With Use of Current Low-Dose Oral Contraceptives Is Not Explained by Diagnostic Suspicion and Referral Bias8.6120Citations (PDF)
110Excess Cancer Mortality in Six Dutch Pedigrees with the Familial Atypical Multiple Mole-Melanoma Syndrome from 1830 to 19942.346Citations (PDF)
111Medical journals and the shaping of medical knowledge*
Lancet, The, 1998, 352, 2001-2006
52.8102Citations (PDF)
112Factor V Leiden and Fatal Pulmonary Embolism
Thrombosis and Haemostasis, 1998, 79, 511-516
4.261Citations (PDF)
113Hemostatic Effects of Oral Contraceptives in Women who Developed Deep-vein Thrombosis while Using Oral Contraceptives
Thrombosis and Haemostasis, 1998, 80, 382-387
4.255Citations (PDF)
114Fever of Unknown Origin (FUO): I. A prospective multicenter study of 167 patients with FUO, using fixed epidemiologic entry criteria
Medicine (United States), 1997, 76, 392-400
1.3266Citations (PDF)
115Risk of oral contraceptives and recency of market introduction
Contraception, 1997, 55, 191-192
1.215Citations (PDF)
116Mortality and Causes of Death in Families With the Factor V Leiden Mutation (Resistance to Activated Protein C)
Blood, 1997, 89, 1963-1967
4.287Citations (PDF)
117Third-generation oral contraceptive and deep venous thrombosis: From epidemiologic controversy to new insight in coagulation2.472Citations (PDF)
118The role of compliance as a cause of instability in oral anticoagulant therapy2.458Citations (PDF)
119Risk factors of peptic ulcer disease: Different impact of Helicobacter pylori in Dutch and Japanese populations?2.715Citations (PDF)
120Hyperhomocysteinemia as a Risk Factor for Deep-Vein Thrombosis43.71,027Citations (PDF)
121Cervical carcinoma in surinam
1996, 77, 1329-1333
16Citations (PDF)
122The mortality of rheumatoid vasculitis compared with rheumatoid arthritis
Arthritis and Rheumatism, 1996, 39, 266-271
6.070Citations (PDF)
123Factor V Leiden: should we screen oral contraceptive users and pregnant women?
BMJ: British Medical Journal, 1996, 313, 1127-1130
0.1189Citations (PDF)
124Decreased Mortality among Contemplative Monks in the Netherlands3.417Citations (PDF)
125RE: “INVITED COMMENTARY: A CRITICAL LOOK AT SOME POPULAR META-ANALYTIC METHODS”
American Journal of Epidemiology, 1995, 142, 1007-1008
3.42Citations (PDF)
126A century of mortality in five large families with polycystic kidney disease1.419Citations (PDF)
127Resistance to Activated Protein C and Factor V Leiden as Risk Factors for Venous Thrombosis
Thrombosis and Haemostasis, 1995, 74, 449-453
4.2137Citations (PDF)
128Achlorhydria does not protect against benign upper gastrointestinal ulcers during NSAID use2.337Citations (PDF)
129John Hageman's factor and deep‐vein thrombosis: Leiden Thrombophilia Study2.4126Citations (PDF)
130Frejka pillow and Becker device for congenital dislocation of the hip: Prospective 6-year study of 104 late-diagnosed cases
Acta Orthopaedica, 1993, 64, 305-311
0.07Citations (PDF)
131Psychologic Distress as a Longterm Predictor of Medical Utilisation1.414Citations (PDF)
132Psychiatric disorders in relation to medical illness among patients of a general medical out-patient clinic
Psychological Medicine, 1993, 23, 167-173
4.2142Citations (PDF)
133THE FIRST AUTHOR REPLIES3.40Citations (PDF)
134Long-term prognosis after partial gastrectomy for benign conditions
Gastroenterology, 1991, 101, 148-153
1.025Citations (PDF)
135Geographical Variance in the Risk of Gastric Stump Cancer: No Increased Risk in Japan?1.926Citations (PDF)
136On a Possible Protective Effect of HLA-A11 Against Skin Cancer and Keratotic Skin Lesions in Renal Transplant Recipients2.349Citations (PDF)
137The influence of the diagnostic technique on the histopathological diagnosis in malignant mesothelioma1.428Citations (PDF)
138Relation between Skin Cancer and HLA Antigens in Renal-Transplant Recipients43.7183Citations (PDF)
139THE FIRST AUTHOR REPLIES3.42Citations (PDF)
140INCIDENCE OF SKIN CANCER AFTER RENAL TRANSPLANTATION IN THE NETHERLANDS
Transplantation, 1990, 49, 506-509
1.2649Citations (PDF)
141PREDICTION OF OSTEOPOROTIC FRACTURES IN THE GENERAL POPULATION BY A FRACTURE RISK SCORE3.464Citations (PDF)
142Reduction of the risk of rheumatoid arthritis among women who take oral contraceptives
Arthritis and Rheumatism, 1990, 33, 173-179
6.091Citations (PDF)
143Diminished incidence of severe rheumatoid arthritis associated with oral contraceptive use
Arthritis and Rheumatism, 1990, 33, 1462-1465
6.035Citations (PDF)
144Occurrence of non-gastric cancer in the digestive tract after remote partial gastrectomy: Analysis of an Amsterdam cohort4.534Citations (PDF)
145Hierarchy of methods3.71Citations (PDF)
146Metacarpal bone loss in middle-aged women: “Horse racing” in a 9-year population based follow-up study3.740Citations (PDF)
147THOSE WHO WERE WRONG3.427Citations (PDF)
148SEX HORMONE BINDING GLOBULIN IN POSTMENOPAUSAL WOMEN: A PREDICTOR OF OSTEOPOROSIS SUPERIOR TO ENDOGENOUS OESTROGENS
Clinical Endocrinology, 1989, 31, 499-509
2.564Citations (PDF)
149AN AUTOPSY OF EPIDEMIOLOGIC METHODS: THE CASE OF “POPPERS” IN THE EARLY EPIDEMIC OF THE ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS)3.448Citations (PDF)
150RE: “BREAST CANCER BEFORE AGE 45 AND ORAL CONTRACEPTIVE USE: NEW FINDINGS”
American Journal of Epidemiology, 1989, 130, 1254-1254
3.41Citations (PDF)
151Weighing Alternatives17.14Citations (PDF)
152Importance of body weight in determining rise and level of blood pressure in postmenopausal women
Journal of Hypertension, 1988, 6, S614-616
2.316Citations (PDF)
153A NOTE ON THE HISTORY OF THE CALCULATION OF HOSPITAL STATISTICS3.414Citations (PDF)
154Letters to the Editor5.10Citations (PDF)
155SHOULD WE ABANDON STATISTICAL MODELING ALTOGETHER?13.444Citations (PDF)
156HISTORICAL INTERPRETATIONS OF THE DECLINE OF TUBERCULOSIS MORTALITY3.41Citations (PDF)
157A check-list for observational research?
Journal of Chronic Diseases, 1987, 40, 1067-1068
1.48Citations (PDF)
158A short note on the history of the randomized controlled trial
Journal of Chronic Diseases, 1987, 40, 985-987
1.421Citations (PDF)
159Scoring of prudent dietary habits and its relation to 25-year survival1.535Citations (PDF)
160Is the randomized controlled trial the real paradigm in epidemiology?1.44Citations (PDF)
161COFFEE DRINKING AND MORTALITY IN A 25-YEAR FOLLOW-UP3.425Citations (PDF)
162DIETARY SODIUM, CALCIUM, AND POTASSIUM, AND BLOOD PRESSURE
American Journal of Epidemiology, 1986, 123, 1043-1048
3.470Citations (PDF)
163Retinopathy as an Independent Indicator of All-Causes Mortality5.121Citations (PDF)
164Noncontraceptive Hormones and Rheumatoid Arthritis in Perimenopausal and Postmenopausal Women17.191Citations (PDF)
165SURVIVAL AND EXPECTATION OF LIFE FROM THE 1400's TO THE PRESENT A STUDY OF THE KNIGHTHOOD ORDER OF THE GOLDEN FLEECE
American Journal of Epidemiology, 1985, 122, 1007-1016
3.413Citations (PDF)
166Radio-synovectomy in chronic synovitis of the knee joint in patients with rheumatoid arthritis1.040Citations (PDF)
167Weight, Smoking, and Mortality17.152Citations (PDF)
168PARENTAL SURVIVAL, AN INDEPENDENT PREDICTOR OF LONGEVITY IN MIDDLE-AGED PERSONS3.441Citations (PDF)
169A SHORTCUT METHOD FOR CALCULATING THE 95 PER CENT CONFIDENCE INTERVAL OF THE STANDARDIZED MORTALITY RATIO3.4172Citations (PDF)
170MORE ON INDEPENDENCE AND INTERACTION3.42Citations (PDF)
171Prophylactic corticosteroids for cardiopulmonary bypass in adults2.460Citations (PDF)
172Authors’ Reply to: VanderWeele<i>et al.</i>, Chiolero, and Schooling<i>et al.</i>5.19Citations (PDF)
173Causation, mediation and explanation5.112Citations (PDF)